CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- 144 Insider Sale of Securities
- 4 Open-market sale 10% owner sold 197,500 shares at $15.00 ($2,962,500)
- 4 Planned sale President and CEO sold 12,000 shares at $13.81 ($165,691)
- 144 Insider Sale of Securities
- 4 Open-market sale 10% owner sold 440,000 shares at $16.00 ($7,040,000)
- SC 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement · Agreement ended
- S-3 Offering Registration Statement
- 8-K Event Shareholder vote results · Other events
- 4 Option exercise Director acquired 2,125 shares (option exercise)
- 4 Option exercise Director acquired 2,125 shares (option exercise)
- 10-Q Report Quarterly Report
Page 26 of 40 · 798 filings